Cosmetics and FDA regulation /:
Gespeichert in:
| Weitere Verfasser: | , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
New York :
Nova Science Publishers,
2013.
|
| Schriftenreihe: | Advertising: media, marketing and cosumer demands.
Government procedures and operations. Novinka (Series) |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Beschreibung: | 1 online resource (ix 102 pages) |
| Bibliographie: | Includes bibliographical references and index. |
| ISBN: | 9781622578931 1622578937 |
Internformat
MARC
| LEADER | 00000cam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | ZDB-4-EBA-ocn961912216 | ||
| 003 | OCoLC | ||
| 005 | 20241004212047.0 | ||
| 006 | m o d | ||
| 007 | cr cnu---unuuu | ||
| 008 | 161102s2013 nyu ob 001 0 eng d | ||
| 040 | |a N$T |b eng |e rda |e pn |c N$T |d YDX |d EBLCP |d OCLCF |d OCLCQ |d OCLCO |d OCLCQ |d OCLCO |d K6U |d OCLCQ |d OCLCO |d INARC |d OCLCL | ||
| 019 | |a 961937480 | ||
| 020 | |a 9781622578931 |q (electronic bk.) | ||
| 020 | |a 1622578937 |q (electronic bk.) | ||
| 020 | |z 9781622578924 | ||
| 020 | |z 1622578929 | ||
| 035 | |a (OCoLC)961912216 |z (OCoLC)961937480 | ||
| 043 | |a n-us--- | ||
| 050 | 4 | |a KF3896 |b .C67 2013eb | |
| 072 | 7 | |a LAW |x 001000 |2 bisacsh | |
| 082 | 7 | |a 344.730423 |2 23 | |
| 049 | |a MAIN | ||
| 245 | 0 | 0 | |a Cosmetics and FDA regulation / |c Adam Garcia and Rose DiBartolo, editors. |
| 264 | 1 | |a New York : |b Nova Science Publishers, |c 2013. | |
| 300 | |a 1 online resource (ix 102 pages) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 490 | 1 | |a Advertising: media, marketing and consumer demands | |
| 490 | 1 | |a Government procedures and operations | |
| 490 | 1 | |a Novinka | |
| 504 | |a Includes bibliographical references and index. | ||
| 588 | 0 | |a Print version record. | |
| 505 | 0 | |a Preface; FDA Regulation of Cosmetics and Personal Care Products*; Summary; Introduction; Cosmetics, Drugs, and Combination Products; Cosmetics; Drugs; Cosmetics Containing Drug Ingredients; Overview of FDA's Authority to Regulate Cosmetics; Adulterated and Misbranded Cosmetics; Adulteration; Misbranding and Mislabeling Claims; Enforcement; Voluntary Recalls; Premarket Approval; Testing and Safety of Cosmetic Ingredients; Cosmetic Ingredient Review Program; Consumer Concerns About the Safety of Ingredients; Concerns About Specific Ingredients; Color Additives; Coal Tar Hair Dyes | |
| 505 | 8 | |a Nanomaterial IngredientsNanotechnology Task Force; Draft Guidance Regarding the Use of Nanomaterials in FDA-Regulated Products; Voluntary Cosmetic Registration Program; Reporting of Adverse Reactions to Cosmetics; Other Concerns with Labeling; "Organic" Labeling Claims on Cosmetic Products; "Not Tested on Animals" Labeling; "For Professional Use Only" Labeling; Conclusion; Appendix. Keratin Hair Treatments, Also Known as "Brazilian Blowouts"; Background; Formaldehyde; OSHA Formaldehyde Standards; Adverse Event Reports; NIOSH and OSHA Investigations; Actions by Other Countries | |
| 505 | 8 | |a Cosmetic Ingredient Review AnalysisAn Assessment of FDA's Authorities; End Notes; Background Memorandum for the Hearing on ''Examining the Current State of Cosmetics''*; II. Background; Statement of Joseph R. Pitts, Chairman, the Subcommittee on Health. Hearing on ''Examining the Current State of Cosmetics''*; Statement of Michael M. Landa, Director, Center for Food Safety and Applied Nutrition, Food and Drug Administration. Hearing on ''Examining the Current State of Cosmetics''*; Introduction; Current Authorities and Activities Related to Cosmetic Safety; Challenges | |
| 505 | 8 | |a FY 2013 President's BudgetConclusion; End Note; Testimony of Halyna Breslawec, Chief Scientist, Personal Care Products Council. Hearing on ''Examining the Current State of Cosmetics''*; Testimony of Peter Barton Hutt, Senior Counsel, Covington and Burling, LLP. Hearing on ''Examining the Current State of Cosmetics''*; Testimony of Curran Dandurland, Co-Founder and CEO, Jack Black Skincare. Hearing on ''Examining the Current State of Cosmetics''*; Testimony of Deborah May, President and CEO, Wholesale Supplies Plus, Inc. Hearing on ''Examining the Current State of Cosmetics''* | |
| 505 | 8 | |a Testimony of Dr. Michael DiBartolomeis, Chief of the Safe Cosmetics Program, California Department of Public Health. Hearing on ''Examining the Current State of Cosmetics''*Index; Blank Page | |
| 610 | 1 | 0 | |a United States. |b Food and Drug Administration. |0 http://id.loc.gov/authorities/names/n80126147 |
| 610 | 1 | 7 | |a United States. |b Food and Drug Administration |2 fast |
| 650 | 0 | |a Cosmetic |z United States |x Safety measures. | |
| 650 | 0 | |a Cosmetics |x Law and legislation |z United States. | |
| 650 | 0 | |a Cosmetics industry |x Safety regulations |z United States. | |
| 650 | 0 | |a Cosmetics industry |z United States. | |
| 650 | 6 | |a Cosmétiques |x Industrie |x Sécurité |x Règlements |z États-Unis. | |
| 650 | 6 | |a Cosmétiques |x Industrie |z États-Unis. | |
| 650 | 7 | |a LAW |x Administrative Law & Regulatory Practice. |2 bisacsh | |
| 650 | 7 | |a Cosmetics industry |2 fast | |
| 650 | 7 | |a Cosmetics |x Law and legislation |2 fast | |
| 651 | 7 | |a United States |2 fast |1 https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq | |
| 700 | 1 | |a Garcia, Adam |q (Adam Gabriel), |e editor. | |
| 700 | 1 | |a DiBartolo, Rose, |e editor. | |
| 776 | 0 | 8 | |i Print version: |t Cosmetics and FDA regulation. |d New York : Nova Science Publishers, 2013 |z 9781622578924 |w (DLC) 2012537150 |w (OCoLC)820781086 |
| 830 | 0 | |a Advertising: media, marketing and cosumer demands. | |
| 830 | 0 | |a Government procedures and operations. | |
| 830 | 0 | |a Novinka (Series) | |
| 856 | 4 | 0 | |l FWS01 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1406211 |3 Volltext |
| 938 | |a Internet Archive |b INAR |n isbn_9781622578924 | ||
| 938 | |a ProQuest Ebook Central |b EBLB |n EBL4743923 | ||
| 938 | |a EBSCOhost |b EBSC |n 1406211 | ||
| 938 | |a YBP Library Services |b YANK |n 13238650 | ||
| 994 | |a 92 |b GEBAY | ||
| 912 | |a ZDB-4-EBA | ||
| 049 | |a DE-863 | ||
Datensatz im Suchindex
| DE-BY-FWS_katkey | ZDB-4-EBA-ocn961912216 |
|---|---|
| _version_ | 1816882367855329280 |
| adam_text | |
| any_adam_object | |
| author2 | Garcia, Adam (Adam Gabriel) DiBartolo, Rose |
| author2_role | edt edt |
| author2_variant | a g ag r d rd |
| author_facet | Garcia, Adam (Adam Gabriel) DiBartolo, Rose |
| building | Verbundindex |
| bvnumber | localFWS |
| callnumber-first | K - Law |
| callnumber-label | KF3896 |
| callnumber-raw | KF3896 .C67 2013eb |
| callnumber-search | KF3896 .C67 2013eb |
| callnumber-sort | KF 43896 C67 42013EB |
| callnumber-subject | KF - United States |
| collection | ZDB-4-EBA |
| contents | Preface; FDA Regulation of Cosmetics and Personal Care Products*; Summary; Introduction; Cosmetics, Drugs, and Combination Products; Cosmetics; Drugs; Cosmetics Containing Drug Ingredients; Overview of FDA's Authority to Regulate Cosmetics; Adulterated and Misbranded Cosmetics; Adulteration; Misbranding and Mislabeling Claims; Enforcement; Voluntary Recalls; Premarket Approval; Testing and Safety of Cosmetic Ingredients; Cosmetic Ingredient Review Program; Consumer Concerns About the Safety of Ingredients; Concerns About Specific Ingredients; Color Additives; Coal Tar Hair Dyes Nanomaterial IngredientsNanotechnology Task Force; Draft Guidance Regarding the Use of Nanomaterials in FDA-Regulated Products; Voluntary Cosmetic Registration Program; Reporting of Adverse Reactions to Cosmetics; Other Concerns with Labeling; "Organic" Labeling Claims on Cosmetic Products; "Not Tested on Animals" Labeling; "For Professional Use Only" Labeling; Conclusion; Appendix. Keratin Hair Treatments, Also Known as "Brazilian Blowouts"; Background; Formaldehyde; OSHA Formaldehyde Standards; Adverse Event Reports; NIOSH and OSHA Investigations; Actions by Other Countries Cosmetic Ingredient Review AnalysisAn Assessment of FDA's Authorities; End Notes; Background Memorandum for the Hearing on ''Examining the Current State of Cosmetics''*; II. Background; Statement of Joseph R. Pitts, Chairman, the Subcommittee on Health. Hearing on ''Examining the Current State of Cosmetics''*; Statement of Michael M. Landa, Director, Center for Food Safety and Applied Nutrition, Food and Drug Administration. Hearing on ''Examining the Current State of Cosmetics''*; Introduction; Current Authorities and Activities Related to Cosmetic Safety; Challenges FY 2013 President's BudgetConclusion; End Note; Testimony of Halyna Breslawec, Chief Scientist, Personal Care Products Council. Hearing on ''Examining the Current State of Cosmetics''*; Testimony of Peter Barton Hutt, Senior Counsel, Covington and Burling, LLP. Hearing on ''Examining the Current State of Cosmetics''*; Testimony of Curran Dandurland, Co-Founder and CEO, Jack Black Skincare. Hearing on ''Examining the Current State of Cosmetics''*; Testimony of Deborah May, President and CEO, Wholesale Supplies Plus, Inc. Hearing on ''Examining the Current State of Cosmetics''* Testimony of Dr. Michael DiBartolomeis, Chief of the Safe Cosmetics Program, California Department of Public Health. Hearing on ''Examining the Current State of Cosmetics''*Index; Blank Page |
| ctrlnum | (OCoLC)961912216 |
| dewey-full | 344.730423 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 344 - Labor, social, education & cultural law |
| dewey-raw | 344.730423 |
| dewey-search | 344.730423 |
| dewey-sort | 3344.730423 |
| dewey-tens | 340 - Law |
| discipline | Rechtswissenschaft |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>05435cam a2200721 i 4500</leader><controlfield tag="001">ZDB-4-EBA-ocn961912216</controlfield><controlfield tag="003">OCoLC</controlfield><controlfield tag="005">20241004212047.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr cnu---unuuu</controlfield><controlfield tag="008">161102s2013 nyu ob 001 0 eng d</controlfield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">N$T</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="e">pn</subfield><subfield code="c">N$T</subfield><subfield code="d">YDX</subfield><subfield code="d">EBLCP</subfield><subfield code="d">OCLCF</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">K6U</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">INARC</subfield><subfield code="d">OCLCL</subfield></datafield><datafield tag="019" ind1=" " ind2=" "><subfield code="a">961937480</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781622578931</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1622578937</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9781622578924</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">1622578929</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)961912216</subfield><subfield code="z">(OCoLC)961937480</subfield></datafield><datafield tag="043" ind1=" " ind2=" "><subfield code="a">n-us---</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">KF3896</subfield><subfield code="b">.C67 2013eb</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">LAW</subfield><subfield code="x">001000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="082" ind1="7" ind2=" "><subfield code="a">344.730423</subfield><subfield code="2">23</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">MAIN</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Cosmetics and FDA regulation /</subfield><subfield code="c">Adam Garcia and Rose DiBartolo, editors.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York :</subfield><subfield code="b">Nova Science Publishers,</subfield><subfield code="c">2013.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (ix 102 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Advertising: media, marketing and consumer demands</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Government procedures and operations</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Novinka</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index.</subfield></datafield><datafield tag="588" ind1="0" ind2=" "><subfield code="a">Print version record.</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Preface; FDA Regulation of Cosmetics and Personal Care Products*; Summary; Introduction; Cosmetics, Drugs, and Combination Products; Cosmetics; Drugs; Cosmetics Containing Drug Ingredients; Overview of FDA's Authority to Regulate Cosmetics; Adulterated and Misbranded Cosmetics; Adulteration; Misbranding and Mislabeling Claims; Enforcement; Voluntary Recalls; Premarket Approval; Testing and Safety of Cosmetic Ingredients; Cosmetic Ingredient Review Program; Consumer Concerns About the Safety of Ingredients; Concerns About Specific Ingredients; Color Additives; Coal Tar Hair Dyes</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Nanomaterial IngredientsNanotechnology Task Force; Draft Guidance Regarding the Use of Nanomaterials in FDA-Regulated Products; Voluntary Cosmetic Registration Program; Reporting of Adverse Reactions to Cosmetics; Other Concerns with Labeling; "Organic" Labeling Claims on Cosmetic Products; "Not Tested on Animals" Labeling; "For Professional Use Only" Labeling; Conclusion; Appendix. Keratin Hair Treatments, Also Known as "Brazilian Blowouts"; Background; Formaldehyde; OSHA Formaldehyde Standards; Adverse Event Reports; NIOSH and OSHA Investigations; Actions by Other Countries</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Cosmetic Ingredient Review AnalysisAn Assessment of FDA's Authorities; End Notes; Background Memorandum for the Hearing on ''Examining the Current State of Cosmetics''*; II. Background; Statement of Joseph R. Pitts, Chairman, the Subcommittee on Health. Hearing on ''Examining the Current State of Cosmetics''*; Statement of Michael M. Landa, Director, Center for Food Safety and Applied Nutrition, Food and Drug Administration. Hearing on ''Examining the Current State of Cosmetics''*; Introduction; Current Authorities and Activities Related to Cosmetic Safety; Challenges</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">FY 2013 President's BudgetConclusion; End Note; Testimony of Halyna Breslawec, Chief Scientist, Personal Care Products Council. Hearing on ''Examining the Current State of Cosmetics''*; Testimony of Peter Barton Hutt, Senior Counsel, Covington and Burling, LLP. Hearing on ''Examining the Current State of Cosmetics''*; Testimony of Curran Dandurland, Co-Founder and CEO, Jack Black Skincare. Hearing on ''Examining the Current State of Cosmetics''*; Testimony of Deborah May, President and CEO, Wholesale Supplies Plus, Inc. Hearing on ''Examining the Current State of Cosmetics''*</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Testimony of Dr. Michael DiBartolomeis, Chief of the Safe Cosmetics Program, California Department of Public Health. Hearing on ''Examining the Current State of Cosmetics''*Index; Blank Page</subfield></datafield><datafield tag="610" ind1="1" ind2="0"><subfield code="a">United States.</subfield><subfield code="b">Food and Drug Administration.</subfield><subfield code="0">http://id.loc.gov/authorities/names/n80126147</subfield></datafield><datafield tag="610" ind1="1" ind2="7"><subfield code="a">United States.</subfield><subfield code="b">Food and Drug Administration</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Cosmetic</subfield><subfield code="z">United States</subfield><subfield code="x">Safety measures.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Cosmetics</subfield><subfield code="x">Law and legislation</subfield><subfield code="z">United States.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Cosmetics industry</subfield><subfield code="x">Safety regulations</subfield><subfield code="z">United States.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Cosmetics industry</subfield><subfield code="z">United States.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Cosmétiques</subfield><subfield code="x">Industrie</subfield><subfield code="x">Sécurité</subfield><subfield code="x">Règlements</subfield><subfield code="z">États-Unis.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Cosmétiques</subfield><subfield code="x">Industrie</subfield><subfield code="z">États-Unis.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">LAW</subfield><subfield code="x">Administrative Law & Regulatory Practice.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cosmetics industry</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cosmetics</subfield><subfield code="x">Law and legislation</subfield><subfield code="2">fast</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">United States</subfield><subfield code="2">fast</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Garcia, Adam</subfield><subfield code="q">(Adam Gabriel),</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">DiBartolo, Rose,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Print version:</subfield><subfield code="t">Cosmetics and FDA regulation.</subfield><subfield code="d">New York : Nova Science Publishers, 2013</subfield><subfield code="z">9781622578924</subfield><subfield code="w">(DLC) 2012537150</subfield><subfield code="w">(OCoLC)820781086</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Advertising: media, marketing and cosumer demands.</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Government procedures and operations.</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Novinka (Series)</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="l">FWS01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1406211</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">Internet Archive</subfield><subfield code="b">INAR</subfield><subfield code="n">isbn_9781622578924</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ProQuest Ebook Central</subfield><subfield code="b">EBLB</subfield><subfield code="n">EBL4743923</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBSCOhost</subfield><subfield code="b">EBSC</subfield><subfield code="n">1406211</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">YBP Library Services</subfield><subfield code="b">YANK</subfield><subfield code="n">13238650</subfield></datafield><datafield tag="994" ind1=" " ind2=" "><subfield code="a">92</subfield><subfield code="b">GEBAY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-863</subfield></datafield></record></collection> |
| geographic | United States fast https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq |
| geographic_facet | United States |
| id | ZDB-4-EBA-ocn961912216 |
| illustrated | Not Illustrated |
| indexdate | 2024-11-27T13:27:30Z |
| institution | BVB |
| isbn | 9781622578931 1622578937 |
| language | English |
| oclc_num | 961912216 |
| open_access_boolean | |
| owner | MAIN DE-863 DE-BY-FWS |
| owner_facet | MAIN DE-863 DE-BY-FWS |
| physical | 1 online resource (ix 102 pages) |
| psigel | ZDB-4-EBA |
| publishDate | 2013 |
| publishDateSearch | 2013 |
| publishDateSort | 2013 |
| publisher | Nova Science Publishers, |
| record_format | marc |
| series | Advertising: media, marketing and cosumer demands. Government procedures and operations. Novinka (Series) |
| series2 | Advertising: media, marketing and consumer demands Government procedures and operations Novinka |
| spelling | Cosmetics and FDA regulation / Adam Garcia and Rose DiBartolo, editors. New York : Nova Science Publishers, 2013. 1 online resource (ix 102 pages) text txt rdacontent computer c rdamedia online resource cr rdacarrier Advertising: media, marketing and consumer demands Government procedures and operations Novinka Includes bibliographical references and index. Print version record. Preface; FDA Regulation of Cosmetics and Personal Care Products*; Summary; Introduction; Cosmetics, Drugs, and Combination Products; Cosmetics; Drugs; Cosmetics Containing Drug Ingredients; Overview of FDA's Authority to Regulate Cosmetics; Adulterated and Misbranded Cosmetics; Adulteration; Misbranding and Mislabeling Claims; Enforcement; Voluntary Recalls; Premarket Approval; Testing and Safety of Cosmetic Ingredients; Cosmetic Ingredient Review Program; Consumer Concerns About the Safety of Ingredients; Concerns About Specific Ingredients; Color Additives; Coal Tar Hair Dyes Nanomaterial IngredientsNanotechnology Task Force; Draft Guidance Regarding the Use of Nanomaterials in FDA-Regulated Products; Voluntary Cosmetic Registration Program; Reporting of Adverse Reactions to Cosmetics; Other Concerns with Labeling; "Organic" Labeling Claims on Cosmetic Products; "Not Tested on Animals" Labeling; "For Professional Use Only" Labeling; Conclusion; Appendix. Keratin Hair Treatments, Also Known as "Brazilian Blowouts"; Background; Formaldehyde; OSHA Formaldehyde Standards; Adverse Event Reports; NIOSH and OSHA Investigations; Actions by Other Countries Cosmetic Ingredient Review AnalysisAn Assessment of FDA's Authorities; End Notes; Background Memorandum for the Hearing on ''Examining the Current State of Cosmetics''*; II. Background; Statement of Joseph R. Pitts, Chairman, the Subcommittee on Health. Hearing on ''Examining the Current State of Cosmetics''*; Statement of Michael M. Landa, Director, Center for Food Safety and Applied Nutrition, Food and Drug Administration. Hearing on ''Examining the Current State of Cosmetics''*; Introduction; Current Authorities and Activities Related to Cosmetic Safety; Challenges FY 2013 President's BudgetConclusion; End Note; Testimony of Halyna Breslawec, Chief Scientist, Personal Care Products Council. Hearing on ''Examining the Current State of Cosmetics''*; Testimony of Peter Barton Hutt, Senior Counsel, Covington and Burling, LLP. Hearing on ''Examining the Current State of Cosmetics''*; Testimony of Curran Dandurland, Co-Founder and CEO, Jack Black Skincare. Hearing on ''Examining the Current State of Cosmetics''*; Testimony of Deborah May, President and CEO, Wholesale Supplies Plus, Inc. Hearing on ''Examining the Current State of Cosmetics''* Testimony of Dr. Michael DiBartolomeis, Chief of the Safe Cosmetics Program, California Department of Public Health. Hearing on ''Examining the Current State of Cosmetics''*Index; Blank Page United States. Food and Drug Administration. http://id.loc.gov/authorities/names/n80126147 United States. Food and Drug Administration fast Cosmetic United States Safety measures. Cosmetics Law and legislation United States. Cosmetics industry Safety regulations United States. Cosmetics industry United States. Cosmétiques Industrie Sécurité Règlements États-Unis. Cosmétiques Industrie États-Unis. LAW Administrative Law & Regulatory Practice. bisacsh Cosmetics industry fast Cosmetics Law and legislation fast United States fast https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq Garcia, Adam (Adam Gabriel), editor. DiBartolo, Rose, editor. Print version: Cosmetics and FDA regulation. New York : Nova Science Publishers, 2013 9781622578924 (DLC) 2012537150 (OCoLC)820781086 Advertising: media, marketing and cosumer demands. Government procedures and operations. Novinka (Series) FWS01 ZDB-4-EBA FWS_PDA_EBA https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1406211 Volltext |
| spellingShingle | Cosmetics and FDA regulation / Advertising: media, marketing and cosumer demands. Government procedures and operations. Novinka (Series) Preface; FDA Regulation of Cosmetics and Personal Care Products*; Summary; Introduction; Cosmetics, Drugs, and Combination Products; Cosmetics; Drugs; Cosmetics Containing Drug Ingredients; Overview of FDA's Authority to Regulate Cosmetics; Adulterated and Misbranded Cosmetics; Adulteration; Misbranding and Mislabeling Claims; Enforcement; Voluntary Recalls; Premarket Approval; Testing and Safety of Cosmetic Ingredients; Cosmetic Ingredient Review Program; Consumer Concerns About the Safety of Ingredients; Concerns About Specific Ingredients; Color Additives; Coal Tar Hair Dyes Nanomaterial IngredientsNanotechnology Task Force; Draft Guidance Regarding the Use of Nanomaterials in FDA-Regulated Products; Voluntary Cosmetic Registration Program; Reporting of Adverse Reactions to Cosmetics; Other Concerns with Labeling; "Organic" Labeling Claims on Cosmetic Products; "Not Tested on Animals" Labeling; "For Professional Use Only" Labeling; Conclusion; Appendix. Keratin Hair Treatments, Also Known as "Brazilian Blowouts"; Background; Formaldehyde; OSHA Formaldehyde Standards; Adverse Event Reports; NIOSH and OSHA Investigations; Actions by Other Countries Cosmetic Ingredient Review AnalysisAn Assessment of FDA's Authorities; End Notes; Background Memorandum for the Hearing on ''Examining the Current State of Cosmetics''*; II. Background; Statement of Joseph R. Pitts, Chairman, the Subcommittee on Health. Hearing on ''Examining the Current State of Cosmetics''*; Statement of Michael M. Landa, Director, Center for Food Safety and Applied Nutrition, Food and Drug Administration. Hearing on ''Examining the Current State of Cosmetics''*; Introduction; Current Authorities and Activities Related to Cosmetic Safety; Challenges FY 2013 President's BudgetConclusion; End Note; Testimony of Halyna Breslawec, Chief Scientist, Personal Care Products Council. Hearing on ''Examining the Current State of Cosmetics''*; Testimony of Peter Barton Hutt, Senior Counsel, Covington and Burling, LLP. Hearing on ''Examining the Current State of Cosmetics''*; Testimony of Curran Dandurland, Co-Founder and CEO, Jack Black Skincare. Hearing on ''Examining the Current State of Cosmetics''*; Testimony of Deborah May, President and CEO, Wholesale Supplies Plus, Inc. Hearing on ''Examining the Current State of Cosmetics''* Testimony of Dr. Michael DiBartolomeis, Chief of the Safe Cosmetics Program, California Department of Public Health. Hearing on ''Examining the Current State of Cosmetics''*Index; Blank Page United States. Food and Drug Administration. http://id.loc.gov/authorities/names/n80126147 United States. Food and Drug Administration fast Cosmetic United States Safety measures. Cosmetics Law and legislation United States. Cosmetics industry Safety regulations United States. Cosmetics industry United States. Cosmétiques Industrie Sécurité Règlements États-Unis. Cosmétiques Industrie États-Unis. LAW Administrative Law & Regulatory Practice. bisacsh Cosmetics industry fast Cosmetics Law and legislation fast |
| subject_GND | http://id.loc.gov/authorities/names/n80126147 |
| title | Cosmetics and FDA regulation / |
| title_auth | Cosmetics and FDA regulation / |
| title_exact_search | Cosmetics and FDA regulation / |
| title_full | Cosmetics and FDA regulation / Adam Garcia and Rose DiBartolo, editors. |
| title_fullStr | Cosmetics and FDA regulation / Adam Garcia and Rose DiBartolo, editors. |
| title_full_unstemmed | Cosmetics and FDA regulation / Adam Garcia and Rose DiBartolo, editors. |
| title_short | Cosmetics and FDA regulation / |
| title_sort | cosmetics and fda regulation |
| topic | United States. Food and Drug Administration. http://id.loc.gov/authorities/names/n80126147 United States. Food and Drug Administration fast Cosmetic United States Safety measures. Cosmetics Law and legislation United States. Cosmetics industry Safety regulations United States. Cosmetics industry United States. Cosmétiques Industrie Sécurité Règlements États-Unis. Cosmétiques Industrie États-Unis. LAW Administrative Law & Regulatory Practice. bisacsh Cosmetics industry fast Cosmetics Law and legislation fast |
| topic_facet | United States. Food and Drug Administration. United States. Food and Drug Administration Cosmetic United States Safety measures. Cosmetics Law and legislation United States. Cosmetics industry Safety regulations United States. Cosmetics industry United States. Cosmétiques Industrie Sécurité Règlements États-Unis. Cosmétiques Industrie États-Unis. LAW Administrative Law & Regulatory Practice. Cosmetics industry Cosmetics Law and legislation United States |
| url | https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1406211 |
| work_keys_str_mv | AT garciaadam cosmeticsandfdaregulation AT dibartolorose cosmeticsandfdaregulation |